When did Eton Pharmaceuticals, Inc. report Q4 2024 earnings?

Eton Pharmaceuticals, Inc. (ETON) reported Q4 2024 earnings on March 18, 2025 before market open.

What were Eton Pharmaceuticals, Inc.'s Q4 2024 revenue and EPS?

Eton Pharmaceuticals, Inc. reported revenue of $11.6M and diluted EPS of $-0.02 for Q4 2024.

Did Eton Pharmaceuticals, Inc. beat estimates in Q4 2024?

Revenue missed the consensus estimate of $14.3M by $2.7M. EPS beat the consensus estimate of $-0.02 by $0.00.

Where can I find Eton Pharmaceuticals, Inc.'s Q4 2024 SEC filings?

You can read the 10-K periodic report (0001437749-25-008136) directly on SEC EDGAR. The filing index links above go to sec.gov.

Eton Pharmaceuticals, Inc. ETON Q4 2024 Annual earnings

Reported March 18, 2025 · Before market open

Revenue$11.6MMiss by $2.7M Diluted EPS-$0.02In line

Revenue estimate$14.3M

EPS estimate-$0.02

Next report

Aug 6, 2026 (In 3 weeks)

Revenue estimate$26.9M

EPS estimate$0.13

Financials

Q4 2024

Income statement

See full

Revenue$11.6M+59.3%

Gross profit$6.5M+78.4%

Net income-$598.0K+73.5%

Balance sheet

See full

Cash & equivalents$14.9M-30.2%

Total debt$30.0M+450%

Total equity$24.4M+57.8%

Total assets$76.1M+140%

Cash flow

See full

CapEx$12.0K—

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$347.01M+209%

Enterprise value$362.06M+275%

P/S8.9×+5.3×

Profitability

See full

Gross margin60%-6.5pp

Net margin-9.8%-17.3pp

Returns & leverage

See full

Return on equity-19.2%-39.9pp

Debt / equity1.2×+0.9×

Current ratio2.1×+0.4×

Versus estimates

Revenue

Q1 2026$24.3MBeat by $2.0M Q4 2025$21.3MBeat by $1.3M Q3 2025$22.5MBeat by $2.0M Q2 2025$18.9MMiss by $1.5M Q1 2025$17.3MBeat by $2.2M

Q4 2024$11.6MMiss by $2.7M

Diluted EPS

Q1 2026$0.05Miss by $0.05 Q4 2025$0.05Miss by $0.07 Q3 2025-$0.07Miss by $0.23 Q2 2025-$0.10Miss by $0.09 Q1 2025$0.07Miss by $0.02

Q4 2024-$0.02In line

Ask the moment Eton Pharmaceuticals, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Eton Pharmaceuticals, Inc. report Q4 2024 earnings?: Eton Pharmaceuticals, Inc. (ETON) reported Q4 2024 earnings on March 18, 2025 before market open.
What were Eton Pharmaceuticals, Inc.'s Q4 2024 revenue and EPS?: Eton Pharmaceuticals, Inc. reported revenue of $11.6M and diluted EPS of $-0.02 for Q4 2024.
Did Eton Pharmaceuticals, Inc. beat estimates in Q4 2024?: Revenue missed the consensus estimate of $14.3M by $2.7M. EPS beat the consensus estimate of $-0.02 by $0.00.
Where can I find Eton Pharmaceuticals, Inc.'s Q4 2024 SEC filings?: You can read the 10-K periodic report (0001437749-25-008136) directly on SEC EDGAR. The filing index links above go to sec.gov.